Central Serous Chorioretinopathy (CSC)
3 clinical trials · Condition
◉ Watch Central Serous Chorioretinopathy (CSC)
| Record | Firm | Date |
|---|---|---|
| Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial (NCT07681167) | Singapore National Eye Centre | 2026-12-01 |
| Prospective Geometric Analysis of Ultra-Widefield OCTA Characteristics in Central Serous Chorioretinopathy Patients (NCT07347119) | Sun Yat-sen University | 2025-12-18 |
| Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD (NCT01256580) | Massachusetts Eye and Ear Infirmary | 2010-08-01 |
Track Central Serous Chorioretinopathy (CSC) automatically
Every clearance here is in the API, with alerts when new ones post.